← Back to patent-cliff list
CAS 102191-92-4
2-((tert-butyldimethylsilyl)oxy)acetaldehyde
Codes: PLAZ-008
Application context (from source-drug indications)
Bacterial infectionPlazomicin sulfateHospital-acquired pneumoniaPlazomicin sulfateUrinary tract infectionPlazomicin sulfatePyelonephritisPlazomicin sulfateEnd-stage renal diseasePlazomicin sulfate肠杆菌科感染Plazomicin sulfate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Plazomicin sulfate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
PLAZ-001→PLAZ-002→PLAZ-003→PLAZ-004→(S)-4-((tert-butoxycarbonyl)amino)-2-hydroxybutanoic acid→PLAZ-006→PLAZ-007→2-((tert-butyldimethylsilyl)oxy)acetaldehyde→PLAZ-009→(S)-4-amino-2-hydroxybutanoic acid
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.